If you experience unexpected symptoms after starting BPC-157-whether physical discomfort, unusual fatigue, changes in mood, or any concerning signs-discontinue use and consult a healthcare provider for evaluation
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
As a leading PCD Pharma Company, we are committed to providing high-quality, affordable, and innovative healthcare solutions across the globe
10mg per vial Primary Benefits Suppresses inflammatory cytokines through melanocortin receptor activation
